StreetAlpha
13F holdings · Q3 2026

Monashee Investment Management

Boston, MA · files as Monashee Investment Management LLC
Know the moment Monashee Investment Management filesYou follow Monashee Investment Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 6, 2026Next filing due Feb 15, 2027CIK 1627608

Monashee Investment Management reported 16 stocks worth $33.4M in its 13F filing for Q3 2026, filed Nov 6, 2026. Its largest holdings are AXON (14.8%), IMMX (14.0%) and SYY (12.8%). Compared with Q2 2026, the fund opened new positions in AXON, IMMX and SYY, trimmed ADT, SLDB and IMA and sold out of DLR, SYRE and TNGX.

Latest filing: what Monashee Investment Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
13 new0 added3 trimmed17 sold outBought about $26.6M · sold about $45.5M
New 13
See all 13 →
Added 0

None

Trimmed 3
  • SLDB−$651K−18%
  • ADT−$608K−17%
  • IMA−$70K−8%
Sold out 17
  • Alphabet Inc$5.1M
  • Alphabet Inc$5M
  • DLR$4.5M
  • SYRE$4.4M
  • TNGX$3.1M
See all 17 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$33.4M−38.3% vs last quarter
Stocks held1613 new · 17 sold out
Top 5 weight60.1%very concentrated
Turnover216%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
AXON
Axon Enterprise Inc
$4.9M14.8%5MNew position1 of 8
2
IMMX
Immix Biopharma Inc
$4.7M14.0%450KNew position1 of 8
3
SYY
Sysco Corp
$4.3M12.8%55KNew position1 of 8
4
NWCL
Newcleo PLC
$3.1M9.4%400KNew position1 of 8
5
ADT
Adt Inc Del
$3M9.1%500K−100K (−17%)7 of 8
6
SLDB
Solid Biosciences Inc
$3M8.9%410K−90K (−18%)7 of 8
7
ENB
Enbridge Inc F
$2.3M7.0%50KNew position1 of 8
8
VKTX
Viking Therapeutics Inc
$1.5M4.6%1.5MNew position1 of 8
9
BLSM
Blossomhill Therapeutics Inc
$1.5M4.5%80KNew position1 of 8
10
ETRA
Electra Therapeutics Inc
$1.1M3.4%100KNew position1 of 8
🔒 6 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ALPHABET INC
$5.1M100K
ALPHABET INC
$5M100K
DLR
Digital Rlty TR Inc
$4.5M25K
SYRE
Spyre Therapeutics Inc
$4.4M50K
TNGX
Tango Therapeutics Inc
$3.1M100K

🔒 Free account: see all 17.

Reported value

last 8 quarters
$725MQ4 '24
$844MQ1 '25
$186MQ2 '25
$198MQ3 '25
$176MQ4 '25
$184MQ1 '26
$54.2MQ2 '26
$33.4MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 6, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Monashee Investment Management 13F FAQ

What does Monashee Investment Management own?

Monashee Investment Management reported 16 stocks worth $33.4M in its 13F filing for Q3 2026, filed Nov 6, 2026. Its largest holdings are AXON (14.8%), IMMX (14.0%) and SYY (12.8%). The table above lists every position in the filing (the top 10 without an account).

What did Monashee Investment Management buy and sell in Q3 2026?

Compared with Q2 2026: 13 new positions, 0 added to, 3 trimmed and 17 sold out. New positions include AXON, IMMX and SYY. It sold all of DLR, SYRE and TNGX.

When will Monashee Investment Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Monashee Investment Management's portfolio worth?

The Q3 2026 filing reports $33.4M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.